論文(英文)
Tanaka Y, Oba K, Takeuchi T. Response to: ‘Comment on ‘Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial’ by Tanaka et al’ by Berkhout et al. Ann Rheum Dis. 2019 Dec 9:annrheumdis-2019-216593.
Tanaka Y, Oba K, Takeuchi T. Response to: 'Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al' by Berkhout et al. Ann Rheum Dis. 2019 Dec 9:annrheumdis-2019-216593.